Abstract
An extracellular proteinase (PSCP) produced by Pseudomonas cepacia was purified from culture supernatants by ammonium sulfate precipitation, anion exchange chromatography on DEAE-Sephacel, and G200 gel filtration chromatography. The protease has an apparent Mr of 34,000 by electrophoresis. Substrates cleaved by the protease include gelatin, hide powder, and collagen but not human immunoglobulin G (IgG), IgM, secretory IgA, or IgA. The enzyme had the characteristics of a metalloprotease, a pH optimum of 6, and a temperature optimum of 45 degrees C. Intratracheal instillation of purified PSCP into rat lungs produced a bronchopneumonia characterized by polymorphonuclear cell infiltration and proteinaceous exudation into large airways. Rats responded immunologically to active immunization with PSCP, but this response was not protective against subsequent lung infection with P. cepacia. PSCP was shown to have antigenic similarity with Pseudomonas aeruginosa elastase by an immunoblotting technique. Sera from 10 cystic fibrosis patients, with and without a previous history of P. cepacia colonization, were shown to possess antibody reactive against PSCP.
MeSH Terms
Amino Acids/analysis
Animals
Antibodies, Bacterial/immunology
Antigens, Bacterial/isolation & purification
Chromatography
Collagen/metabolism
Cystic Fibrosis/immunology
Enzyme-Linked Immunosorbent Assay
Extracellular Space/enzymology
Fluorescent Antibody Technique
Humans
Immunization
Metalloendopeptidases/immunology,isolation & purification,toxicity
Molecular Weight
Protease Inhibitors/pharmacology
Pseudomonas/enzymology,immunology,pathogenicity
Rats
Substrate Specificity
Chemicals
Amino Acids
Antibodies, Bacterial
Antigens, Bacterial
Protease Inhibitors
Collagen
Metalloendopeptidases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
McKevitt A I
Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Centre, Alberta, Canada.
Bajaksouzian S
Klinger J D
Woods D E
References (25)
25 references, click to expand
-
Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals.
J Infect Dis. 1985 Apr;151(4):581-8
PMID: 3919114
-
Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia.
Infect Immun. 1983 Sep;41(3):1099-104
PMID: 6885156
-
Pseudomonas cepacia septicemia in patients with burns: report of two cases.
Scand J Infect Dis. 1985;17(1):63-6
PMID: 3992208
-
Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.
Am Rev Respir Dis. 1985 May;131(5):791-6
PMID: 3923882
-
Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.
Infect Immun. 1985 Sep;49(3):557-62
PMID: 3928491
-
Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology.
J Pediatr. 1986 May;108(5 Pt 2):806-12
PMID: 3517271
-
Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease.
Infect Immun. 1986 Oct;54(1):149-53
PMID: 3093382
-
PSEUDOMONAS AERUGINOSA PEPTIDE PEPTIDOHYDROLASE. IV. OPTICAL ROTATORY DISPERSION AND AMINO ACID COMPOSITION.
Biochim Biophys Acta. 1964 Nov 22;92:361-6
PMID: 14249124
-
PSEUDOMONAS AERUGINOSA ELASTASE. ISOLATION, CRYSTALLIZATION, AND PRELIMINARY CHARACTERIZATION.
J Biol Chem. 1965 Aug;240:3295-304
PMID: 14321366
-
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
J Pediatr. 1984 Feb;104(2):206-10
PMID: 6420530
-
Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis.
J Clin Microbiol. 1984 Feb;19(2):291-3
PMID: 6699152
-
Estimation of the molecular weights of proteins by Sephadex gel-filtration.
Biochem J. 1964 May;91(2):222-33
PMID: 4158310
-
A new ultrasensitive method for the determination of proteolytic activity.
Clin Chim Acta. 1968 Aug;21(2):197-203
PMID: 4299134
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature. 1970 Aug 15;227(5259):680-5
PMID: 5432063
-
Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
J Infect Dis. 1978 Jul;138(1):49-8
PMID: 98596
-
Effectiveness of immunization with single and multi-component vaccines prepared from a common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa.
Jpn J Exp Med. 1978 Apr;48(2):111-33
PMID: 101698
-
Microscopic characterization of rabbit lung damage produced by Pseudomonas aeruginosa proteases.
Infect Immun. 1979 Jan;23(1):150-9
PMID: 106001
-
Bacteriocin, plasmid and pectolytic diversity in Pseudomonas cepacia of clinical and plant origin.
J Gen Microbiol. 1979 Jan;110(1):161-70
PMID: 430027
-
A rat model of chronic respiratory infection with Pseudomonas aeruginosa.
Am Rev Respir Dis. 1979 Mar;119(3):453-9
PMID: 109021
-
Proteins and polypeptides as antigens.
Methods Enzymol. 1980;70(A):49-70
PMID: 7421601
-
Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.
Johns Hopkins Med J. 1980 Nov;147(5):188-9
PMID: 7441939
-
[Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA (author's transl)].
Zentralbl Bakteriol A. 1981 Mar;249(1):89-98
PMID: 6791405
-
Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
J Clin Microbiol. 1982 Jun;15(6):1054-8
PMID: 6809785
-
Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination.
Am J Med. 1982 Aug;73(2):183-6
PMID: 7114074
-
IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis.
J Infect Dis. 1985 Apr;151(4):589-98
PMID: 3919115